[A case of pulmonary artery pseudoaneurysm secondary to lung abscess]

Hiromi Kobayashi1, Makiko Kiyokawa, Mami Fukuoka

  • 1Department of Pulmonary Medicine, Saga University School of Medicine.

Insights

A patient with uncontrolled diabetes developed a lung abscess and pulmonary pseudoaneurysm, leading to recurrent hemoptysis. Embolization successfully controlled bleeding, highlighting the need for precise evaluation in such cases.

Area of Science:

  • Pulmonology
  • Radiology
  • Vascular Surgery

Background:

  • A 53-year-old male with a history of uncontrolled diabetes mellitus presented with chest pain and cough.
  • Initial diagnosis of pneumonia was complicated by poor medication compliance, leading to worsening symptoms.

Observation:

  • The patient developed hemoptysis, and a contrast-enhanced CT scan revealed a lung abscess with an associated pulmonary pseudoaneurysm.
  • Despite initial antibiotic treatment (SBT/ABPC), massive hemoptysis recurred.

Findings:

  • Embolization of the bronchial artery and pulmonary pseudoaneurysm was performed.
  • The embolization procedure successfully controlled the airway bleeding.

Implications:

  • This case underscores the importance of considering pulmonary artery bleeding in cases of hemoptysis associated with sustained inflammation, such as lung abscess.
  • Accurate diagnosis requires precise evaluation, including contrast-enhanced CT and pulmonary angiography.

Related Concept Videos

Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
621
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
480
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
523
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
138.1K
Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
2.1K